利用比利时系列血清学数据识别麻疹免疫空白
该研究基于贝叶斯方法构建简单队列模型,利用比利时2002、2006和2013年三次横断面血清学调查数据及疫苗特性信息,评估麻疹血清流行率演变。研究发现比利时不同地区麻疹血清流行率特征相似,在常规疫苗接种启动后最初几年接种覆盖率次优的出生队列中出现血清流行率下降,该免疫空白在所有调查年份均可见,2013年调查年更为明显。
要点
- 比利时不同地区麻疹血清流行率特征相似。
- 常规接种启动初期覆盖率次优的出生队列存在免疫空白,2013年调查年更明显。
- COVID-19大流行可能负面影响全球免疫覆盖率,增加额外免疫规划需求。
核心结论
- 比利时不同地区麻疹血清流行率特征相似。
- 在常规疫苗接种启动后最初几年接种覆盖率次优的出生队列中出现血清流行率下降,形成免疫空白。
- 该免疫空白在所有横断面调查年份均可见,2013年调查年更为明显。
- COVID-19大流行可能负面影响全球免疫覆盖率,增加受影响儿童群体额外免疫规划的需求,识别现有免疫空白并维持和达到疫苗诱导的麻疹免疫目标更为重要。
研究设计与样本
- 研究构建了依赖贝叶斯方法的简单队列模型,利用比利时最近三次横断面血清学调查数据收集(2002年、2006年和2013年)及疫苗特性信息,评估麻疹血清流行率演变。
主要发现
- 比利时不同地区麻疹血清流行率特征相似。
- 常规疫苗接种启动后最初几年接种覆盖率次优的出生队列出现血清流行率下降。
- 该免疫空白在所有横断面调查年份均可见,2013年调查年更为明显。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccine-preventable diseases, such as measles, have been re-emerging in countries with moderate to high vaccine uptake. It is increasingly important to identify and close immunity gaps and increase coverage of routine childhood vaccinations, including two doses of the measles-mumps-rubella vaccine (MMR). Here, we present a simple cohort model relying on a Bayesian approach to evaluate the evolution of measles seroprevalence in Belgium using the three most recent cross-sectional serological survey data collections (2002, 2006 and 2013) and information regarding vaccine properties. We find measles seroprevalence profiles to be similar for the different regions in Belgium. These profiles exhibit a drop in seroprevalence in birth cohorts that were offered vaccination at suboptimal coverages in the first years after routine vaccination has been started up. This immunity gap is observed across all cross-sectional survey years, although it is more pronounced in survey year 2013. At present, the COVID-19 pandemic could negatively impact the immunization coverage worldwide, thereby increasing the need for additional immunization programs in groups of children that are impacted by this. Therefore, it is now even more important to identify existing immunity gaps and to sustain and reach vaccine-derived measles immunity goals.
引用
- Schenk J, Abrams S, Litzroth A, et al. Identifying immunity gaps for measles using Belgian serial serology data. Vaccine. 2022. PMID: 35589453. doi:10.1016/j.vaccine.2022.05.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。